INDSWIFT LABORATORIES
|
INDSWIFT LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.97 | 36.44 | 71.24 | 8.06 | -0.36 |
| CEPS(Rs) | 8.48 | 40.00 | 80.35 | 17.80 | 21.81 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 159.28 | 159.86 | 157.64 | 84.25 | 68.33 |
| Tax Rate(%) | 15.23 | 2.82 | 27.56 | 44.72 | 117.15 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 5.40 | -1.17 | 19.71 | 18.90 | 18.66 |
| EBIT Margin(%) | 7.67 | 44.47 | 49.07 | 14.74 | 10.31 |
| Pre Tax Margin(%) | 7.47 | 43.97 | 45.11 | 7.14 | 1.20 |
| PAT Margin (%) | 6.33 | 42.73 | 32.68 | 3.94 | -0.21 |
| Cash Profit Margin (%) | 10.83 | 46.91 | 36.81 | 8.68 | 12.30 |
| Performance Ratios | |||||
| ROA(%) | 2.85 | 19.83 | 28.79 | 2.70 | -0.12 |
| ROE(%) | 3.47 | 24.68 | 58.97 | 10.61 | -0.54 |
| ROCE(%) | 4.00 | 24.24 | 55.13 | 13.25 | 7.88 |
| Asset Turnover(x) | 0.45 | 0.46 | 0.88 | 0.68 | 0.60 |
| Sales/Fixed Asset(x) | 1.01 | 1.77 | 1.93 | 0.92 | 0.80 |
| Working Capital/Sales(x) | 0.95 | 0.91 | 2.93 | 1.53 | 1.42 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.99 | 0.56 | 0.52 | 1.09 | 1.25 |
| Receivable days | 97.45 | 103.86 | 95.44 | 144.51 | 154.46 |
| Inventory Days | 70.35 | 38.80 | 63.55 | 130.51 | 140.01 |
| Payable days | 162.26 | 129.43 | 82.21 | 105.77 | 106.89 |
| Valuation Parameters | |||||
| PER(x) | 26.50 | 2.30 | 1.38 | 6.86 | - |
| PCE(x) | 15.52 | 2.10 | 1.22 | 3.10 | 3.04 |
| Price/Book(x) | 0.83 | 0.53 | 0.62 | 0.66 | 0.97 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.13 | 0.32 | 0.13 | 0.96 | 1.26 |
| EV/Core EBITDA(x) | 7.79 | 2.98 | 0.54 | 4.42 | 5.49 |
| EV/EBIT(x) | 14.01 | 0.71 | 0.26 | 6.49 | 12.15 |
| EV/CE(x) | 0.52 | 0.15 | 0.17 | 0.86 | 0.75 |
| M Cap / Sales | 1.76 | 1.01 | 0.45 | 0.27 | 0.38 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.04 | -55.17 | 6.10 | 16.23 | 16.54 |
| Core EBITDA Growth(%) | 51.27 | -79.31 | 14.04 | 9.86 | 16.35 |
| EBIT Growth(%) | -79.99 | -58.80 | 254.17 | 65.33 | -8.58 |
| PAT Growth(%) | -82.83 | -40.56 | 781.13 | 2,325.72 | 31.72 |
| EPS Growth(%) | -86.37 | -48.86 | 784.43 | 2,314.84 | 31.72 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.03 | 0.01 | 1.71 | 2.33 |
| Current Ratio(x) | 3.80 | 3.92 | 2.99 | 3.13 | 3.21 |
| Quick Ratio(x) | 3.22 | 3.41 | 2.94 | 1.95 | 1.93 |
| Interest Cover(x) | 37.13 | 89.31 | 12.38 | 1.94 | 1.13 |
| Total Debt/Mcap(x) | 0.02 | 0.06 | 0.02 | 2.61 | 2.40 |
Compare Financial Ratios of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,025.5 Cr | -7.4% | -8.3% | 242.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -7.4% |
-8.3% |
242.7% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses
